Efficacy of the Flo App in Improving Health Literacy, Menstrual and General Health, and Well-Being in Women: Pilot Randomized Controlled Trial (Preprint)
Authors: Cunningham Adam C , Prentice Carley , Peven Kimberly , Wickham Aidan , Bamford Ryan , Radovic Tara , Klepchukova Anna , Fomina Maria , Cunningham Katja , Hill Sarah , Hantsoo Liisa , Payne Jennifer , Zhaunova Liudmila , Ponzo Sonia 
Published: November 2023

BACKGROUND

Reproductive health literacy and menstrual health awareness play a crucial role in ensuring the health and well-being of women and people who menstruate. Further, awareness of one’s own menstrual cycle patterns and associated symptoms can help individuals identify and manage conditions of the menstrual cycle such as premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). Digital health products, and specifically menstrual health apps, have the potential to effect positive change due to their scalability and ease of access.

OBJECTIVE

The primary aim of this study was to measure the efficacy of a menstrual and reproductive health app, Flo, in improving health literacy and health and well-being outcomes in menstruating individuals with and without PMS and PMDD. Further, we explored the possibility that the use of the Flo app could positively influence feelings around reproductive health management and communication about health, menstrual cycle stigma, unplanned pregnancies, quality of life, work productivity, absenteeism, and body image.

METHODS

We conducted 2 pilot, 3-month, unblinded, 2-armed, remote randomized controlled trials on the effects of using the Flo app in a sample of US-based (1) individuals who track their cycles (n=321) or (2) individuals who track their cycles and are affected by PMS or PMDD (n=117).

RESULTS

The findings revealed significant improvements at the end of the study period compared to baseline for our primary outcomes of health literacy (cycle tracking: D̄=1.11; <i>t</i><sub>311</sub>=5.73, <i>P</i>&lt;.001; PMS or PMDD: D̄=1.20; <i>t</i><sub>115</sub>=3.76, <i>P</i>&lt;.001) and menstrual health awareness (D̄=3.97; <i>t</i><sub>311</sub>=7.71, <i>P</i>&lt;.001), health and well-being (D̄=3.44; <i>t</i><sub>311</sub>=5.94, <i>P</i>&lt;.001), and PMS or PMDD symptoms burden (D̄=–7.08; <i>t</i><sub>115</sub>=–5.44, <i>P</i>&lt;.001). Improvements were also observed for our secondary outcomes of feelings of control and management over health (D̄=1.01; <i>t</i><sub>311</sub>=5.08, <i>P</i>&lt;.001), communication about health (D̄=0.93; <i>t</i><sub>311</sub>=2.41, <i>P</i>=.002), menstrual cycle stigma (D̄=–0.61; <i>t</i><sub>311</sub>=–2.73, <i>P</i>=.007), and fear of unplanned pregnancies (D̄=–0.22; <i>t</i><sub>311</sub>=–2.11, <i>P</i>=.04) for those who track their cycles, as well as absenteeism from work and education due to PMS or PMDD (D̄=–1.67; <i>t</i><sub>144</sub>=–2.49, <i>P</i>=.01).

CONCLUSIONS

These pilot randomized controlled trials demonstrate that the use of the Flo app improves menstrual health literacy and awareness, general health and well-being, and PMS or PMDD symptom burden. Considering the widespread use and affordability of the Flo app, these findings show promise for filling important gaps in current health care provisioning such as improving menstrual knowledge and health.

CLINICALTRIAL

OSF Registries osf.io/pcgw7; https://osf.io/pcgw7 ; OSF Registries osf.io/ry8vq; https://osf.io/ry8vq